Overview
Prevention of Contrast-Induced Nephropathy in Diabetic Patients With Undergoing Coronary Angiography
Status:
Unknown status
Unknown status
Trial end date:
2010-01-01
2010-01-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The aim of this study is to determine whether sodium bicarbonate is superior to sodium chloride in preventing contrast induced nephropathy in diabetic patients undergoing coronary angiography or intervention.Phase:
Phase 4Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
CardioVascular Research Foundation, Korea
Criteria
Inclusion Criteria:- age>18 years, no upper limits
- diabetes treated with insulin or oral hypoglycemic agents
- serum creatinine >=1.1 and
- resting estimated glomerular filtration rate <60ml/min/1.73 square meter
Exclusion Criteria:
- serum creatinine >=8mg/dL
- resting estimated GFR <15ml/min/1.73 square meter
- end stage renal disease on hemodialysis
- multiple myeloma
- uncontrolled hypertension (systolic BP >160mmHg or diastolic BP>100mmHg)
- acute myocardial infarction
- emergent coronary angioplasty or angiography
- recent use of contrast within 2 days
- allergic reaction to contrast
- pregnancy
- allergic to following medication : theophylline, dopamine, mannitol, fenoldopam,
N-acetylcysteine